Peptika.
Cat. 02
Type I · Lyophilised
PK-2026-THYMOG
Peptika Thymogen vial
Lot-tracedEU pharmacyCold-chain 2–8 °C
02 · Longevity & Anti-aging

Thymogen.

Synthetic dipeptide derived from Thymalin — narrow immunomodulatory profile.

Select strengthPer-vial price
Quantity
1
Total
€60.00· 1 vial

Build your bag, then either book a consultation (an EU-licensed physician reviews your file — anything declined is refunded) or upload an existing Rx at checkout.

  • Magistral preparation — Directive 2001/83/EC Art. 5(1).
  • Patient-named prescription only — dispensed against a valid Rx.
  • EU-GMP Annex 1 Grade A/B cleanroom compounding.
  • Cold-chain shipping across EU/EEA — 2–5 working days.
Overview

About Thymogen.

Thymogen is a synthetic dipeptide (Glu-Trp) derived from the active fragment of Thymalin. It retains much of Thymalin's immunomodulatory activity in a simpler chemical structure.

Like Thymalin, the clinical evidence base is mostly Russian and East-European, with practical use in immune-rebalancing protocols.

Mechanism of action

Thymogen modulates T-helper / T-suppressor cell balance and stimulates the differentiation of immature T-cells in the thymus. It also reduces excessive pro-inflammatory cytokine production.

Posology · for information only

Subcutaneous injection, typically 100 mcg daily for 5–10 day courses.

Your physician sets the prescription. This is descriptive information, not a self-administration guide.

Storage

Lyophilised: store at 2–8 °C, protect from light. Once reconstituted: 2–8 °C, use within 30 days. Do not freeze.

Evidence baseClinical case-series evidence
Indications studied
Immune balanceT-cell maturationInflammation control
Identification & specifications
INN / Name
Thymogen
Form
Lyophilised vial · subcutaneous injection
Strength
5mg vial
Manufacturing
EU-GMP Annex 1 · Grade A/B
Endotoxins
European Pharmacopoeia 2.6.14 · LAL assay
Identity & purity
HPLC + MS · > 98%
Cold chain
Validated 2–8 °C, monitored end-to-end
Regulatory basis
Directive 2001/83/EC · Article 5(1)
Logistics

2–5 working days

EU / EEA cold-chain delivery, 2–8 °C monitored end-to-end with digital temperature log. Tracking link sent on dispatch.

Legal status

Magistral preparation

Patient-named preparation under Directive 2001/83/EC Article 5(1). Dispensed exclusively against a valid EU prescription.

Cross-border

EU prescription recognition

Prescriptions written in one EU member state are recognised in others under Directive 2011/24/EU on cross-border healthcare.